
The Clarity BioSolutions sample preparation portfolio is composed of unique solid phase extraction chemistries packed in 96-well plate and cartridge formats designed to efficiently and effectively purify oligonucleotides.



Prior to LC-MS analysis, therapeutic oligonucleotides must be isolated from interferences such as salts, sugars, large proteins, and genomic DNA. Using a mixed-mode solid phase extraction (SPE) sorbent in conjunction with carefully formulated buffers, Clarity OTX consistently delivers high recoveries.
| Clarity Products | Particle Support | Bonded Phase | Particle Shape/Size (μm) | Pore Size(Å) | Surface Area (m2/g) | 
|---|---|---|---|---|---|
| Polymer (surface modified PSDVB) | Mixed-mode anion exchanger | 33 | 85 | 800 | |
| Polymer (PSDVB) | Hydrophilic polymer coating | 35 | 500 | 300 | |
| Silica | C18 | 55 | 140 | 300 | 
Clarity OTX and Clarity QSP are patented by Phenomenex. U.S. Patent No. 7,119,145